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Expression of Transformation-associated Protease(s) That
Degrade Fibronectin at Cell Contact Sites
ABSTRACT Virus-transformed fibroblasts show an increased production of proteases as well
as loss of extracellular adhesive proteins. To determine whether these transformation-associ-
ated events are related, we investigated the capacity of Rous sarcoma virus-transformed cells
(embryonic chick fibroblasts and mouse BALB/c 3T3) to degrade fibronectin by using a novel
cross-linked protein substratum: fluorescence-labeled or radiolabeled fibronectin covalently
linked to the surface of a fixed gelatin film . In serum-containing medium, the coupled
fibronectin was not released when incubated without cells, and only a small amount was
released when incubated with nontransformed cells. However, when transformed cells were
seeded on the radiolabeled fibronectin-coupled substratum, there was a threefold increase in
the time-dependent release of radioactivity into the medium . The released material was
characterized as peptides with molecular sizes of <30,000 daltons. Correspondingly, growth
of transformed cells on the rhodamine-fibronectin substratum resulted in the appearance of
discrete negative fluorescent spots beneath the cells and along their migratory paths, whereas
a uniform fluorescent carpet was detected with nontransformed cells. The release of radio-
activity was partially inhibited by protease inhibitors, including a,-macroglobulin, leupeptin,
and benzamidine, but the negative fluorescent spots appeared unaffected by any of these
inhibitors . However, both the release of radiolabeled peptides and the appearance of fluores-
cence-negative spots were inhibited by 1,10-phenanthroline at concentrations that did not
affect cellular attachment and protein synthesis, thus supporting a role for proteases in localized
degradation of fibronectin substratum. These fluorescence-negative spots coincided with sites
of fibronectin disappearance as judged by indirect labeling with antibodies to cellular fibro-
nectin. In addition, immunofluorescent analyses showed a correlation between vinculin
localization and the negative fibronectin spots found under transformed cells, indicating that
degradation occurs at cell substratum contact sites. These results can be correlated with other
transformation-associated phenotypic changes, and are discussed in terms of the invasion of
tumor cells into the extracellular matrix.
Fibronectins are largeextracellular glycoproteinsthat promote
the adhesion and spreading offibroblastic cells on collagenous
substrata (see references 17, 29, 36, and 37 for reviews).
Oncogenic transformation of cultured cells by viruses causes
a pleiotropic change in cellular properties including loss of
fibronectin, reduced adhesion, rounded morphology, and loss
of cytoskeletal organization. Because all ofthese changes can
be reverted to some extent by the addition of fibronectins (2,
35, 39), it has been suggested that loss of fibronectin may be
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important for producing the transformed phenotype and may
be associated with detachment and subsequent invasion of
malignant cells in vivo (11, 37). Possible explanations for the
loss of fibronectin in transformed cells include (a) reduced
synthesis (1, 24, 31), (b) reduced binding (15, 20, 33), (c)
increased rates ofdegradation (13, 19), or some combination
of these three possibilities. In particular, loss of fibronectin
has been related to increased production of cell surface pro-
teases in transformed cells(7, 14, 16, 22, 25). These proteases
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from the fibronectin matrix at existing attachment sites, i.e.,
the extracellular matrix (ECM)' contacts in spread fibroblasts
(9).
In this paper, we address the following questions: (a) Does
Rous sarcoma virus (RSV)-transformation increase the
expression of proteolytic activities on the cell surface? (b) Is
fibronectin degraded by these proteases? (c) Are such activities
localized at cell contact sites? To answer these questions, we
have developed â novel substrate for cell surface proteases
that involves the covalent linkage of fluorescence-labeled or
radiolabeled fibronectin to the surface of cross-linked gelatin
substrata (8, 9). Irreversible coupling of fibronectin, or other
proteins, to such a surface prevents lateral interaction and
translocation of the proteins by contact with the cell mem-
brane, as shown with a coating method (3), during the assay.
Fluorescence-labeled fibronectin substrata also permit direct
visualization of fibronectin degradation under the ventral
surface ofthe cells. In using the fluorescence and radiolabeled
probes, we have demonstrated the existence of transforma-
tion-sensitive protease(s) that may be involved in the local
degradation of fibronectin at ECM contact sites.
MATERIALS AND METHODS
Cell Culture:
￿
Primary cultures of embryonic chick fibroblasts (ECF)
were prepared from 10-d-old White Leghorn embryos (Truslow Farms Incor-
porated, Chestertown, MD), and infectedbya wild-type, Schmidt-Ruppin(SR)
strain or temperature-sensitive strain (ts68) (19) ofRSV as previously described
(24). Cells were cultured in Dulbecco's modified Eagle medium containing
4,500 mg/liter ofglucose, 10% fetal calf serum, 10 tag/ml gentamycin (Grand
Island Biological Co., Grand Island, NY), and 2 mM glutamine. Cells were
passed every 2-3 d with trypsinization, and were usually plated at a density of
5 x 10" cells per 35-mm tissue culture dish. In some experiments, BALB/c
mouse 3T3 cells were infected with the SR wild-type strain of RSV and were
cultured as described above.
Fibronectin Coupled to Gelatin Film:
￿
Confluent tertiary cultures
were used for urea extraction and purification ofcellular fibronectin as previ-
ously described (5, 38). To prepare metabolically labeled cellular Fibronectin,
we cultured ECF in media containing [U-"C]leucine (4 uCi/ml, sp act 353
mCi/mmol) or ["S]cysteine (100 uCi/ml, sp act 934 mCi/mmol) for 24 h
before purification of cellular fibronectin as described (5). Bovine plasma
fibronectin was purchased from Bethesda Research Laboratories, Inc. (Gaith-
ersburg, MD). Fibronectin was conjugated to tetramethyl rhodamine isothio-
cyanate (Research Organics, Inc., Cleveland, OH), and conjugates with a
fluorophore-to-protein ratio of 5:1 were separated on DEAE-cellulosecolumns
for use in the present studies (8).
Purified fibronectin, rhodamine conjugates of fibronectin, or metabolically
labeled fibronectin was covalently linked to the surface ofa fixed gelatin film
according to a previously described procedure (8). Briefly, the gelatin solution
(heat-denatured bovine type I collagen, purchased from Sigma Chemical Co.,
St. Louis, MO) was first coated on either No. I glass coverslips or 96-well
microtiter plastic plates and the film was fixed with 4% glutaraldehyde over-
night. The freealdehyde groups on the surface of fixed gelatin film were further
coupled to fibronectin, usually at the concentration of0.1 mg/ml, followed by
quenching and masking of nonspecifically sticky sites with 3% bovine serum
albumin plus 0.1 M glycine. To monitor released radioactive product of
fibronectin in the medium, ['SS]fibronectin was coupled to the substratum at a
concentration of 0.2 mg/ml. Controls for coupling of fibronectin included (a)
reacting with bovine serum albumin instead offibronectin in parallel incuba-
tions, (b) first quenching with glycine, followed by absorption of fibronectin to
the fixedgelatin surface (in that fibronectin has high affinity to unfixed gelatin),
and (c) removing noncovalently bound fibronectin with 4.5 M urea. The
amount of coupled fibronectin was estimated by adding a known amount of
["S]fibronectin, and measuring the amount of unbound protein.
Immunofluorescent Labeling and Microscopy: Antibodies,
secondary antibody conjugates, and procedures for immunolabeling of cells
have been described elsewhere (9). Labeled cells were observed with a Zeiss
' Abbreviations used in this paper. ECF, embryonic chick fibroblasts;
ECM, extracellular matrix; RSV, Rous sarcoma virus; SR, Schmidt-
Ruppin strain; ts68, temperature-sensitive strain.
Photomicroscope III (Carl Zeiss, Inc., New York) equipped with epifluores-
cence. A Plan-neofluar 25/0.8 phase objective (Carl Zeiss, Inc., New York) was
routinely used for low magnification observations offibronectin clearing and a
Planapo 63/.1 .4 objective (Carl Zeiss, Inc.) for high resolution studies on single
cells.
Determination of Proteolytic Activity: To analyze degraded
products of "C- or "S-labeled fibronectin-coupled substrata, we collected
aliquots ofculture media at various time periods after cellularattachment, and
determined radioactivity by liquid scintillation spectrometry. In addition, the
radioactivity remaining associated with the substratum was determined after
Triton X-100 (1%) solubilization ofthecell monolayer, and medium incubated
without cells was used to estimate the nonspecific release ofthe radiolabeled
product. Cells were culturedon the cross-linked gelatin film coated on the well
of flexible assay plates (Falcon 96-well microtiter plates-Micro Test III,
Becton, Dickinson Labware, Oxnard, CA). After removal of media, the cell
layer grown on fibronectin substrata was lysed in 1 % Triton X-100 and the
solution was collected. The substratum was then removed by cutting off the
bottom ofthe well. The molecular size of digestion products released into the
medium was determined by gel filtration chromatography on a Sephadex G-50
column (Pharmacia Fine Chemicals, Piscataway, NJ) (12).
Enzymes and Enzyme Inhibitors: To examine the nature of
putative proteases, we seeded cells in the complete medium containing each of
the following inhibitors at various concentrations indicated in Table I: apro-
tinin, a,-antitrypsin (a,-proteinase inhibitor), 1,10-phenanthroline, soybean
trypsin inhibitor, pepstatin, and benzamidine from Sigma Chemical Co. (St.
Louis, MO); armacroglobulin, dansyl-L.-glutamyl-glycyl-t.-arginine chloro-
methyl ketone dihydrochlorine (DGGACKD), o-phenylalanyl-prolyl-arginine
chloromethyl ketone (PPACK), 2-mercaptomethyl-3-guanidinoethyl thiopro-
panioc acid (Plummer's inhibitor), guanidinoethylmercaptosuccinic acid
(GEMSA), and ZINCOV inhibitor from Calbiochem-Behring Corp. (La Jolla,
CA), and leupeptin from Boehringer-Mannheim Biochemicals (Indianapolis,
IN).
The possibility that fluorescence-negative spots in substrata are due to
masking by other ECM components was examined by treatment of these
substrata with the following enzymes: collagenase from Calbiochem-Behring
Corp., hyaluronidase and chondroitase ABC from Seikagaku Kogyo Co. (To-
kyo, Japan), and Flavobacterium heparanase (a gift from Dr. L. Culp, Case
Western Reserve University, Cleveland, OH).
RESULTS
Attachment and Spreading of Transformed Cells
on Fibronectin Substrata
ECF and their transformed counterparts attached to the
fibronectin-coupled, cross-linked gelatin substratum within
15 min afterplating, and their attachment was similar to that
of ECF grown on plastic dishes. Maximal spreading on the
fibronectin substratum was achieved by 6 h after plating as
compared to that of 18 h on plastic surface.
To determine whether cellular transformation by RSV re-
sultsin increased expression ofproteolytic enzymes at the cell
surface or in the extracellular milieu capable of degrading
fibronectin, we first investigated the effect of cell monolayers
on the rhodamine-labeled fibronectin substrata by visualizing
fibronectin degradation under the ventral surface of the trans-
formed cells. Normal and wild-type SR strain virus-trans-
formed formed ECF were seeded on the rhodamine-fibronectin sub-
stratum at the confluent density of 5 x 10° cells per dish (35
mm) to restrict cell migration. Under these condition fluores-
cence-negative (black) spots began to appear on the substra-
tum of the transformed cell culture within 6 h as shown in
Fig. 1 B. The fluorescence-negative areas increased in size
during the next 18 h (Fig. 1 D), but increased in number only
slightly (cf. Fig. 1 A and B with C and D). However, when
seeded at subconfluent density, the black spots increased in
number and in size (Fig. 1 E-H). These results suggest that
the localized degradation of fibronectin substrata occurs either
directly under the cells or along their migratory pathway.
Transformed cells have been shown to produce elevated
levels of various membrane and soluble proteases (7, 14, 16,
22, 25, 26, 27). These proteases may be involved in overall
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1547removal of fibronectin from areas surrounding black spots .
Accordingly, we examined the difference in the intensity of
fluorescence of the fibronectin substrata as a function of time
of cell incubation . Measurements of the diffuse fluorescence
using the automatic spot reading of Zeiss Photomicroscope
III indicated a twofold reduction in fluorescent intensity from
6- to 24-h cultures. Thus, the general removal of fibronectin
from the surface of the substratum may involve a number of
different proteases that are distinct from those responsible for
the localized degradation characterized by the appearance of
black spots (Fig. 1) .
Localized degradation of fibronectin by transformed cells
may not be restricted to the exogenous protein, inasmuch as
the cell-associated fibronectin may also be degraded. To in-
vestigate this possibility, cells grown on rhodamine-fibronec-
tin substrata were immunolabeled with fluorescein-antibody
conjugates directed against both cellular and substratum fi-
bronectin . The labeled specimens were observed with a high-
resolution x 63 objective using alternative rhodamine and
fluorescein filter settings . The results shown in Fig. 2 reveal a
uniform substratum fluorescence under the normal ECF (Fig.
2B) indicating no detectable proteolytic activity; however,
discrete black spots were detected on the rhodamine-labeled
fibronectin substratum of transformed cells (Fig. 2E), indic-
ative of fibronectin degradation at these areas . In addition,
fluorescence-negative spots on the fibronectin substratum co-
incided with clearing sites of extracellular fibronectin fibers
deposited by cells as shown by indirect labeling with antibod-
ies to fibronectin (Fig. 2F) . These negative immunofluores-
cent spots are not due to masking by proteoglycan and hyal-
uronic acid (21), because treatment ofsubstrata with enzymes
specific for these ECM components produced no apparent
effect on the appearance of the negative immunofluorescent
spots (see below for more details). It is also important to note
that the present method of covalent linkage of fibronectin to
the substratum surface clearly demonstrated the retention of
coupled fibronectin at focal adhesion sites formed between
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TABLE I
Effects of Protease Inhibitors on Degradation of Fibronectin-coupled Substrata by SR-infectedECF
Effect on cellular
DGGACKD, dansyl-L-glutamyl-glycyl-L-arginine chloromethyl ketone dihydrochlorine ; PPACK, D-phenylalanyl-prolyl-arginine chloromethyl ketone; GEMSA,
guandinoethylmercaptosuccinic acid ; ND, not determined .
Toxicity was determined by the reduction of "C-leucine incorporation .
$ Fibronectin clearing by the cells at 6 h culture that showed similar negative spots as in Fig . 1 B was considered positive degradation (designated +); lack of
negative spots on substrata was considered inhibition of degradation (designated -) .
' Radioactivity released from the fibronectin substrata was determined as percentage of total counts released . Results are from triplicate walls .
II In the presence of these inhibitors cells aremore spreaded than the control . All assays in this table were performed at 6h aftercell plating in media containing
10% fetal calf serum .
cells and the substratum (cf . Figs. 2 and 4) . In contrast,
fibronectin coated on the glass surface by the method of
Avnur and Geiger (3) was removed from focal adhesion sites
by both normal and transformed ECF.
When mouse 3T3 cells and SR-transformed 3T3 cells were
tested for fibronectin clearing, negative spots were found
under transformed cells but not under the nontransformed
cells (results not shown) . Thus, the appearance of negative
spots on fibronectin substrata directly corresponded to trans-
formation by RSV.
Initial Sites of Fibronectin Clearing under the
Transformed Cells
When ECF were infected with the SR ts68 and grown at
the permissive temperature (37°C), >40% of the infected cells
produced spots of fibronectin clearing as found for ECF
infected with wild-type virus and grown under similar condi-
tions (Figs . 1 and 2) . However, direct demonstration of initial
sites of fibronectin clearing under the cells requires the use of
868-infected cells . To further investigate the time course of
expression of the proteolytic activity under the transformed
cells, the ts68-infected ECF were seeded on the rhodamine-
fibronectin substratum at the nonpermissive temperature
(41 °C) for 3 h to allow for maximal spreading ; the cultures
were then shifted to the permissive temperature (37°C) for
various periods of times before microscopic examination .
Within 1 h after the temperature shift (Fig. 3A-C), negative
fluorescent spots appeared on the rhodamine-fibronectin sub-
strata (Fig . 3 B), and became more evident after 2 h (Fig. 3 E,
H) . In contrast, a uniform carpet offluorescence was observed
in cultures grown at the nonpermissive temperature . Further-
more, indirect immunofluorescent labeling of these cultures
with fluorescent antibodies, directed against fibronectin, re-
vealed that these negative spots coincided with areas depleted
of the immunoreactive protein (cf . Fig . 2F and Fig. 3F).
These fibronectin-depleted zones could be detected directly
Inhibitors Concentration
attachment and
spreading
Toxicity' (protein
synthesis)
Fibronectin
clearing;
Radioactivity re-
leased'
None (control) - None None + 100%
Soybean trypsin inhibitor 100 tag/ml None ND + ND
Leupeptin 0.5 mM Nonet None + 65%
Benzamidine 2 mM None None + 54%
Aprotinin 200 tag/ml None ND + ND
Pepstatin 0.3 mM Nonel ND + ND
a2-Macroglobulin 0.3 ALM None None + 85%
1,10-Phenanthroline 0.3 mM None None - 56%
a,-Antitrypsin 0.2 mM None ND + ND
DGGACKD 0.3 mM Nonet ND + ND
PPACK 0.4 mM None ND + ND
Plummer's inhibitor 0.4 mM None ND + ND
GEMSA 0.9 mm None ND + ND
ZINCOV inhibitor 0.7 mM Nonel None + 100%beneath the cell body by 1 h after the temperature shift (Fig.
3C and F), and peripheral to the cell after 3 h (Fig . 3I)
suggesting that sites offibronectin clearing correspond to sites
of detachment ofthe cell margin.
Clearing of Fibronectin Substrata at Sites of
Cell Contacts
It was recently shown by immunofluorescence (4) and
immunoelectron microscopy (9) that vinculin, a protein of
M r 130,000, is concentrated at the sites of cell contact on the
cytoplasmic side of the plasma membrane of cultured fibro-
blasts. To determine whether removal of fibronectin also
occurred at sites of cell contact upon transformation, we
immunolabeled vinculin in transformed cells to see if this
protein co-localized with regions offibronectin removal from
the substratum . For these studies, ECF were grown on rho-
damine-fibronectin substrata, lightly fixed with paraformal-
dehyde, permeabilized, and immunolabeled with fluorescein-
antibody conjugates directed against vinculin to show the
correlation between indirect vinculin labeling and direct fi-
bronectin removal . By comparing the immunolabeling pat-
terns of vinculin and rhodamin-fibronectin in ts68-infected
ECF, grown at the permissive and nonpermissive tempera-
tures for 3 h, we found that the ECM contact sites were
present at the ventral surface of normal cells and showed
positive labeling for both vinculin and fibronectin (Fig. 4A
and B). However, the majority of the transformed cells had
lost the ECM contact sites and exhibited a cluster of small
patches that were immunolabeled for vinculin and coincident
removal of fibronectin (Fig . 4D and E) . Such a cluster of
vinculin labeling, previously termed "rosettes" (11), is located
near the ventral surface of the cell, usually partly under the
nucleus . On the extracellular face of the rosette, fibronectin
labeling was usually removed from the substratum (arrows in
Fig. 4D-E) . Thus, clearing of fibronectin substrata on the
ventral surface of the cell appears to occur at sites of rosette
contacts in transformed cells.
Analysis of Fibronectin Degradation
To quantitate fibronectin degradation, we seeded cells on
radiolabeled fibronectin substrata and the release of radioac-
tivity into the culture media was monitored. The time course
of release of radioactivity into the medium (Figs. 5 and 6)
correlated with the number and size of negative fluorescent
spots described above (Fig . 1) . In medium containing 10%
FIGURE 1
￿
Time course of clearing of fibronectin-coupled substrata
under SR-infected ECF grown for 6 h (A and B, and E and F) and 24
h (C, D, and G, H). The cells weré seeded on rhodamine-fibronectin
matrix coupled to cross-linked gelatin film at high cell density (5 x
10°/35-mm dish) (A, B, C, and D) and at low density (5 x 103/35-
mm dish) (E, F, G, and H) . A and C are phase-contrast images and E
and G are Nomarski differential interference contrast images. Black
spots in fluorescent images (B, D, F, and H) indicate areas where
rhodamine-fibronectin substrata have been digested and removed .
Note that the black spots in confluent cultures (B and D) increase
in size as a function of time. An average of 40% of the cells in 6 h
culture (A and B) and in 24 h culture (C and D) shows evidence of
fibronectin clearing . In sparse cultures (F and H), increased number
and size of black spots are seen along the migratory pathway of the
cells (H) . Bar, 50 /m . (A-D) x 200 ; (E-H) x 480 .
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High resolution micrographs of fibronectin substrata under uninfected (A, B, and C) and SR-infected ECF (D, E, and F) .
A and D show the differential interference contrast images of the same cells; B and E are fluorescent images of rhodamine-
fibronectin substrata ; and C and F are fluorescent images of same cells and substrata using fluorescenn-antibody conjugates
directed against both cellular and substratum fibronectin . Under the normal cellsa uniform pattern of fluorescence was observed
on the fibronectin substratum (B) . Under transformed cells, discrete black spots (shown by arrow in E) were detected on the
labeled fibronectin substratum (E), and these spots coincided with sites of clearing of extracellular fibronectin fibers deposited by
cells as shown by indirect labeling with antibodies to fibronectin (shown by arrow in F) . In contrast with localized sites of
fibronectin clearing, focal adhesion sites of both normal and SR-infected ECF were inaccessible to antibody labeling and showed
negative streaks (shown by arrowheads in C and F) which corresponded to areas where fibronectin was present (shown by
arrowheads in B and E) . Bar, 10,um . x 1,200.
fetal bovine serum, the initial release of radioactivity from
the fibronectin substrata was detectable by the 5th hour in
transformed cultures of3T3 (Fig . 5) and ECF (Fig . 6) . By 48
h 33% of radioactive fibronectin originally coupled to the
substratum was released into the medium (Figs. 5 and 6);
whereas, in the nontransformed cultures (Figs. 5 and 6),<10%
of the radioactivity was released under similar conditions.
Some degraded material seems to be endocytosed, inasmuch
as cells lysed with 1% Triton X-100 released an amount of
radioactivity equivalent to -10% of the total radioactivity
found in the medium .
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When the media of normal and transformed cells were
analyzed by Sephadex G-50 gel filtration, threefold more
[
3sS]cysteine counts were found in the included volume ofthe
column with media derived from transformed cells versus
normal cells . In addition, most of the released counts were
not precipitable by 10% trichloroacetic acid, consistent with
the above suggestion that fibronectin fragments released into
media by transformed ECF haveM r of<30,000 daltons . The
degradation of the fibronectin substratum occurred only in
the presence of cells in that conditioned media containing
10% fetal bovine serum were without effect for up to 48 h atFIGURE 3 Demonstration of initial sites of clearing of fibronectin matrix under ts68-infected ECF grown at the permissive
temperature (37°C) for 1 h (A, B, and C), 2 h (D, E, and F), and 3 h (G, H, and 1) after temperature shift from 41 °C . The cells were
seeded on rhodamine-fibronectin layer coupled to cross-linked gelatin film (B, E, and H) and were indirectly labeled with
fluorescein-antibodies to cellular and substratum fibronectin (C, F, and 1) . Differential interference contrast images of the same
cells are shown in the left most panels (A, D, and G) . Negative fluorescent spots on rhodamine-fibronectin substrata (B, E, and H)
represent areas where fibronectin has been cleared . Indirect labeling with fluorescein-antibodies to fibronectin (C, F, and 1) shows
the absence of fibronectin corresponding to the fluorescence-negative spots indicated in B, E, and H . These spots appear under
the cell body immediately after shift to the permissive temperature (C and F) and peripheral to the cell in older cultures (1) . Bar,
10 um . x 1,200 .
￿
1551FIGURE 4 Clearing of fibronectin substrata occurred at transformation-associated, vinculin-rich cell contact sites . (A and C)
Vinculin localization using indirect fluorescein-antibody labeling on ts68-infected ECF grown at the nonpermissive temperature
(41 °C) for 6 h (A) and the cell 3 h after shift to the permissive temperature (37°C) (C) . (B and D) The rhodamine-fibronectin
substratum under the same cells shown in A and C, respectively. (E) The overlay tracing of vinculin localization (shown as dotted
outline) and degraded fibronectin spots (shown as solid black) in the transformed cells indicated in C and D. The identically
positioned arrowheads in the normal cells (A and B) and in the transformed cells (C-E) point to the focal adhesion sites that label
intensely for vinculin but do not remove fibronectin covalently coupled to substrata . The identically positioned arrows in the
normal cell (A and B) point to ECM contacts that lie under the ventral surface of the normal cells, and label for vinculin in the
form of streaks (arrows in A) but do not show fibronectin removal (arrows in B) . ECM contacts are rarely detected in transformed
cells, however, rosette contacts indicated by the identically positioned arrows in C-E are found in transformed cells that label
intensely for vinculin, and produce negative fibronectin spots (E) . Some negative fibronectin spots are seen peripheral to the
transformed cells (E), indicating sites where cells migrated away . Under some rosette contacts in E that label for vinculin, there is
no detectable black spots suggesting that these spots are newly formed rosettes and thus degraded spots are yet to be detected .
Bar, 10 ym . x 1,200 .
37°C .
Because fibronectin was initially coupled to the gelatin film,
the possibility arises that collagenase activity may account for
the release of some ofthe bound fibronectin . Accordingly, we
examined the role of collagenase-like activity in matrix deg-
radation by transformed cells. Replacement of rhodamine-
fibronectin conjugates with rhodamine-gelatin conjugates that
were coupled to the cross-linked gelatin film did not produce
negative fluorescent spots under transformed ECF for up to
48 h in culture ; neither did fluorescence-negative spots appear
when the cross-linked gelatin film was directly conjugated to
rhodamine. Another possibility is that the negative immuno-
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fluorescent spots could be due to masking by other secretory
molecules such as proteoglycan and hyaluronic acid (21) . To
test this possibility, we treated the transformed cell cultures
with the enzymes hyaluronidase (25 TRU/ml), chondroitase
ABC (0 .1 U/ml), or Flavobacterium heparanase (0.02 U/ml)
(21) individually or in combination, and then performed
indirect antibody labeling for fibronectin . These enzymes
produced no apparent effect on the appearance ofthe negative
spots under transformed cells, suggesting that a transforma-
tion-associated protease, expressed at cell contact sites, is
involved in localized degradation of the adhesion protein
fibronectin .Effects of Protease Inhibitors on
Fibronectin Degradation
To provide additional support for the involvement of pro-
tease(s) in localized degradation of fibronectin substrata, we
examined effects of various protease inhibitors on the for-
mation of fluorescence-negative spots and the release of ra-
dioactive fragments using concentrations of inhibitors that
did not significantly affect cellular attachment and spreading
nor amino acid incorporation (Table I). These effects of
inhibitor treatment were evaluated at 6 h after cell plating as
shown in Fig. 1 A and B; >90% of the cells were viable,
as determined by trypan blue exclusion (not shown) and
['"C]leucine incorporation (Table I). In addition, none of the
inhibitors had any major morphological effect on cellular
attachment and spreading on the fibronectin substrata.
It is also significant that leupeptin and benzamidine, inhib-
itors of plasminogen activator activity (25, 26), decreased the
degradation of fibronectin substrata when determined by the
release of radioactivity into the culture medium containing
10% fetal bovine serum, but had no discernible effects on the
formation of the black spots. Of the various inhibitors tested
(see Table I), only 1,10-phenanthroline inhibited formation
of fluorescence-negative spots and the release of radioactivity
into the culture medium. Also, the inhibitory effect of 1,10-
phenanthroline was not reversed by removing it from the
culture medium as expected ofa metal chelator. The concen-
tration of the inhibitor (60 ug/ml) had no effect on cellular
attachment and spreading, nor on protein synthesis. These
results suggest that a transformation-associated metalloendo-
protease is expressed at cell-substratum contact sites capable
of degrading fibronectin.
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FIGURE 5 Time course of release of radioactive peptides from
['"C]fibronectin-coupled substrata by 3T3 cells (0, O) and SR-
infected 3T3 cells (0, p). Open circles (O) and squares (E7) indicate
the substratum counts and solid circles (") and squares (/) show
the medium counts. Cell suspensions were seeded at concentration
of 5 x 10" cells/ml so that the cell layer reaches confluency at 6 h.
Each data point represents the average of triplicate samples (SD
<15%). The curves are fit by linear regression analysis with a
correlation coefficient >0.95.
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FIGURE 6 Time course of release of radioactive peptides from
["S]fibronectin substrata by ECF (p) and SR-infected ECF (/). Cell
density used is identical to that in Fig. 5. In this experiment, excess
["S]cysteine-labeled fibronectins were used to react the crosslinked
gelatin film on wells of 96-well microtiter plates. An average of 6 x
103 cpm of ["S]fibronectin were remained on each well at the time
of seeding cells of which about 3.6 x 103 cpm was estimated as
covalently coupled counts (see Materials and Methods for details).
Each data point represents the mean of triplicate samples (SD
<15%). The curves are fit by linear regression analysis with a
correlation coefficient >0.97.
In view of the characteristically different adhesive properties
ofnormal and transformed cells, it is probable that important
insights into the mechanisms of cell transformation will come
from a knowledge of the molecular nature of extracellular
adhesive proteins, such as fibronectin, and of the changes in
adhesive proteins that are produced by transformation-in-
duced cell surface proteases. Fibronectin, an extracellular
adhesive glycoprotein of fibroblasts and other cells, is usually
absent or found in reduced amounts on the surface of trans-
formed cells (references see 17, 29, 36, and 37 for reviews).
In this article, we have shown that highly localized degradation
of extracellular fibronectin occurs at sites of the rosette con-
tacts to the substratum. In that vinculin may be phosphoryl-
ated by the transforming gene product of RSV-(pp60src) (30)
and both vinculin and pp60' are located at the rosettes (11,
23), our observation that the appearance of the rosettes and
fibronectin degradation occur within 3 h after shift of ts68-
infected ECF is consistent with the notion that the rosettes
andtheir activity are amongthe earlyevents oftransformation
(6). Localized degradation of fibronectin at the rosette con-
tacts could break attachments of the cell membrane to the
substratum and could in turn play an important role in the
rounding up of the cell (6), in the disorganization of the
microfilament bundles (2, 35, 39), and in the decrease in cell-
substratum adhesion (34).
The localized degradation offibronectin at cell contact sites
in cultures of transformed cells may be important in the
regulation ofdetachment, migration, and subsequentinvasion
of cells into the connective tissue. It was recently demon-
strated that cell surface proteases are involved in other proc-
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during implantation (13), the invasion of tumor cells and
migration of endothelial cells through the basement mem-
brane (18), and myoblast fusion (10).
It has been suggested that cell surface proteases may also
be responsible for degradation of extracellular fibronectin
fibers and the morphological changes that accompany cell
transformation; these include plasminogen activator or plas-
min (25-27, 32), and other less well-defined cell surface
proteases (7, 14, 22). Although the nature of the protease
remains to be identified, previous workers (25-27) have re-
ported that enhanced expression of a membrane-associated
protease involved in plasminogen activation is closely correl-
ative with RSV transformation. The present system of cultur-
ing transformed cells on fibronectin-coupled substrata may
be useful in determining the nature ofthe protease(s) involved
in localized degradation of cell surface fibronectin. Our find-
ing that leupeptin and benzamidine, both inhibitors of plas-
minogen activator, blocked the release of radiolabeled degra-
dative fragments, but had no discernible effect on localized
degradation as shown by the fluorescence-fibronectin assay
(Table I), cannot rule out the possibility that a membrane-
bound form of plasminogen-activator is highly concentrated
at sites ofcell-substratum contact and is relatively inaccessible
to inhibitors known to block its activity. Localization experi-
ments using antibody directed against purified plasminogen
activator would be required to test this possibility. However,
the fact that transformed cells do not form negative spots on
rhodamine-gelatin substrata appears to rule out a role for
gelatinases. Inhibitor experiments in this report show that
only 1,10-phenanthroline inhibits both overall and localized
fibronectin degradation.
The negative spots on fibronectin substrata observed may
be due to localized protease secretion by transformed cells, to
membrane proteases on the cell surface, or to endocytosis.
The fact that fibronectin clearance occurs only at contact
sites, and that media conoitioned by transformed cellsdo not
digest fibronectin matrix argues against a secretory product
and favors membrane-associated protease. However, lysis of
the cell layer with detergents releases digested fibronectin,
suggesting that some ofdegraded products were in fact inter-
nalized. The specific removal of fibronectin at rosette-contact
sitesby transformed cellsis the result of membrane-associated
proteolytic activity rather than to a nonenzymatic mechanism
of removal as previously reported for noncovalently coupled
fibronectin on glass surface (3, 9). The results obtained with
nontransformed cells indicate that the appearance of rosette
contacts and degraded fibronectin spots is directly related to
transformation and not to alterations in the physiological
state of the cell.
The rosettes associated with the majority of RSV-trans-
formed cells are implicated as surface protrusions emanating
from the ventral surface forming close contacts with the
substratum (11, 23). They do not appear to be simply the
residual adhesion of RSV-transformed cells to their substrata
(11, 23, 28). We have shown that the rosettes detected by
immunolabeling of vinculin are associated with sites of fibro-
nectin degradation at the ventral surface of the cell. This
suggests a possible role for these structures in the invasion of
RSV-transformed cells into their extracellular matrices. For
example, the redistribution of vinculin upon transformation
may directly reflect intracellular molecular events that change
the expression and localization of the cell surface proteases
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involved in the penetration of cell surface protrusions into
the extracellular matrix. Further work is required (a) to char-
acterize the protease(s) responsible for fibronectin degrada-
tion, and (b) to determine if the rosettes represent defined
ultrastructural entities that are involved in invasive processes
and if they are also present in other neoplastic cells involved
in malignant spreading.
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